Characterization and in vitro dissolution behaviour of ketoconazole/beta- and 2-hydroxypropyl-beta-cyclodextrin inclusion compounds

被引:58
作者
EsclusaDiaz, MT [1 ]
GuimaraensMendez, M [1 ]
PerezMarcos, MB [1 ]
VilaJato, JL [1 ]
TorresLabandeira, JJ [1 ]
机构
[1] UNIV SANTIAGO DE COMPOSTELA,FAC PHARM,DEPT PHARMACEUT TECHNOL,E-15706 SANTIAGO COMPOSTE,SPAIN
关键词
ketoconazole; cyclodextrins; inclusion compounds; dissolution;
D O I
10.1016/S0378-5173(96)04704-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of beta-cyclodextrin and 2-hydroxypropyl-beta-cyclodextrin on the solubility of ketoconazole in different media were studied. A type A(L) solubility diagram was obtained for ketoconazole and the two cyclodextrins in buffer solution, pH 5 and pH 6. The stability constants between ketoconazole and the two cyclodextrins were calculated from the phase solubility diagrams. Increased ionization of the imidazole derivative decreased the values of the stability constants. The formation of solid inclusion complexes were experimentally prepared by the kneading and spray-drying techniques. In other to confirm solid complex formation, X-ray diffractometry and differential scanning calorimetry were used. It was found that the spray-drying technique could be used to prepare the amorphous state of drug inclusion complexes. The dissolution rates of ketoconazole from the inclusion complex made by spray-drying were faster than the pure drug, kneading systems and the physical mixtures of drug and cyclodextrins. The enhanced dissolution rate of spray-dried products might be attributed to the decreased particle size, the high-energetic amorphous state and inclusion complex formation.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 16 条
[1]  
Bender M. L., 1978, CYCLODEXTRIN CHEM, P10
[2]   EFFECT OF PH ON DISINTEGRATION AND DISSOLUTION OF KETOCONAZOLE TABLETS [J].
CARLSON, JA ;
MANN, HJ ;
CANAFAX, DM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (08) :1334-1336
[3]  
DEBEULE K, 1996, 8 INT CYCL S BUD 30
[4]   PHARMACEUTICAL USES OF CYCLODEXTRINS AND DERIVATIVES [J].
DUCHENE, D ;
WOUESSIDJEWE, D .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (17) :2487-2499
[5]   A STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN [J].
ERDEN, N ;
CELEBI, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :83-89
[6]   INCLUSION COMPLEXATION OF GLIBENCLAMIDE WITH 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN IN SOLUTION AND IN SOLID-STATE [J].
ESCLUSADIAZ, MT ;
TORRESLABANDEIRA, JJ ;
KATA, M ;
VILAJATO, JL .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 1 (06) :291-296
[7]  
Higuchi T., 1965, Interscience, New York, V4, P117
[8]   CONCEPT OF DISSOLUTION EFFICIENCY [J].
KHAN, KA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (01) :48-49
[9]  
LIN JH, 1991, MACH LEARN, V6, P211, DOI 10.1007/BF00114777
[10]   STUDIES OF CYCLODEXTRIN INCLUSION COMPLEXES .1. THE SALBUTAMOL-CYCLODEXTRIN COMPLEX AS STUDIED BY PHASE SOLUBILITY AND DSC [J].
MARQUES, HMC ;
HADGRAFT, J ;
KELLAWAY, IW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (03) :259-266